MANAGEMENT

Prof. John F. Currie, Ph.D., Chief Technology Officer: Tenured university physics professor; visiting scientist at Walter Reed Medical Center. His research expertise includes solid state technology for micro-sensing and -actuation, thin film chip microfabrication technologies; nanomaterial fabrication and characterization; and nonintrusive biomolecular monitoring Microsystems with applications in the monitoring of the health and physiological state of individuals as well as disease detection and treatment.

Richard H. Smith, CEO: Richard Smith is CEO of Flexible Medical Systems, a medical diagnostics company with its roots in nanotechnology and with offices in Alexandria, VA and laboratories Rockville, MD. FMS has patents pending for a line of products that will revolutionize the field of non-invasive, painless, continuous, networked “lab-on-a-chip” personal health monitors. Its first two applications have approved protocols for human testing at Walter Reed Army Diabetes Institute and the University of Maryland School of Medicine Shock Trauma Center. Since the early 1970s, Dick has worked in various aspects of science and technology development including strategic planning stints at AT&T, System Development Corporation, and SONY. He was CEO of an Artificial Intelligence R&D start-up. In recent years, he has been a Research Administrator at Georgetown University Medical School, a professional futurist and long-range strategic planner, and a developer of advanced technology intellectual property from universities in the US and abroad.

Peter S. Benton, Chairman: Life sciences specialist: Chief Operating Officer etrials (NASDAQ:ETWC), Managing Director, Wharton Venture Partners, former Vice President, Johnson & Johnson Pharmaceuticals, M&A professional at TRW, Operations professional at GE.

Andrew McCandlish, Ph.D., Manager, Strategic Planning & Business Development: Dr. McCandlish received his Ph.D. in molecular biology from Princeton University .  At Princeton, he identified and characterized novel components of bacterial endotoxin biogenesis in the laboratory of Thomas J. Silhavy.  Prior to that, Andrew studied cell-signaling and development at The Ohio State University where he also completed the Capital Program in Business Marketing at the Fisher College of Business. 

_________________

Dennis M. Dalton, Ph.D., Advisor: Director of Technology at Honeywell Corporation (Specialty Materials Division) advisor to Battelle Ventures, Princeton NJ; formerly Professor Chemistry at Williams College.

Neal Walker, M.D., Advisor: Co-founder of Octagon Research Solutions; Board-certified dermatologist with extensive experience as a consultant to the pharmaceutical industry.

Reuben Mezrich, M.D., Ph.D., Advisor: Chairman of the Department of Diagnostic Radiology and Nuclear Medicine at the University of Maryland School of Medicine.  As both a physician and engineer, Dr. Mezrich has a unique understanding of how innovative technology can be used to extend the frontiers of research and improve patient care.